274 related articles for article (PubMed ID: 32253259)
1. LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover.
Tanaka Y; Shimanaka Y; Caddeo A; Kubo T; Mao Y; Kubota T; Kubota N; Yamauchi T; Mancina RM; Baselli G; Luukkonen P; Pihlajamäki J; Yki-Järvinen H; Valenti L; Arai H; Romeo S; Kono N
Gut; 2021 Jan; 70(1):180-193. PubMed ID: 32253259
[TBL] [Abstract][Full Text] [Related]
2. Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes.
Meroni M; Dongiovanni P; Longo M; Carli F; Baselli G; Rametta R; Pelusi S; Badiali S; Maggioni M; Gaggini M; Fracanzani AL; Romeo S; Gatti S; Davidson NO; Gastaldelli A; Valenti L
EBioMedicine; 2020 Feb; 52():102658. PubMed ID: 32058943
[TBL] [Abstract][Full Text] [Related]
3. The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.
Mancina RM; Dongiovanni P; Petta S; Pingitore P; Meroni M; Rametta R; Borén J; Montalcini T; Pujia A; Wiklund O; Hindy G; Spagnuolo R; Motta BM; Pipitone RM; Craxì A; Fargion S; Nobili V; Käkelä P; Kärjä V; Männistö V; Pihlajamäki J; Reilly DF; Castro-Perez J; Kozlitina J; Valenti L; Romeo S
Gastroenterology; 2016 May; 150(5):1219-1230.e6. PubMed ID: 26850495
[TBL] [Abstract][Full Text] [Related]
4. Loss of hepatic Mboat7 leads to liver fibrosis.
Thangapandi VR; Knittelfelder O; Brosch M; Patsenker E; Vvedenskaya O; Buch S; Hinz S; Hendricks A; Nati M; Herrmann A; Rekhade DR; Berg T; Matz-Soja M; Huse K; Klipp E; Pauling JK; Wodke JA; Miranda Ackerman J; Bonin MV; Aigner E; Datz C; von Schönfels W; Nehring S; Zeissig S; Röcken C; Dahl A; Chavakis T; Stickel F; Shevchenko A; Schafmayer C; Hampe J; Subramanian P
Gut; 2021 May; 70(5):940-950. PubMed ID: 32591434
[TBL] [Abstract][Full Text] [Related]
5. LPIAT1/MBOAT7 contains a catalytic dyad transferring polyunsaturated fatty acids to lysophosphatidylinositol.
Caddeo A; Hedfalk K; Romeo S; Pingitore P
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 May; 1866(5):158891. PubMed ID: 33513444
[TBL] [Abstract][Full Text] [Related]
6. LPIAT1 regulates arachidonic acid content in phosphatidylinositol and is required for cortical lamination in mice.
Lee HC; Inoue T; Sasaki J; Kubo T; Matsuda S; Nakasaki Y; Hattori M; Tanaka F; Udagawa O; Kono N; Itoh T; Ogiso H; Taguchi R; Arita M; Sasaki T; Arai H
Mol Biol Cell; 2012 Dec; 23(24):4689-700. PubMed ID: 23097495
[TBL] [Abstract][Full Text] [Related]
7. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidylinositol-acyltransferase-1 (LPIAT1) is required to maintain physiological levels of PtdIns and PtdInsP(2) in the mouse.
Anderson KE; Kielkowska A; Durrant TN; Juvin V; Clark J; Stephens LR; Hawkins PT
PLoS One; 2013; 8(3):e58425. PubMed ID: 23472195
[TBL] [Abstract][Full Text] [Related]
9. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
[TBL] [Abstract][Full Text] [Related]
10. Identification of small subunit of serine palmitoyltransferase a as a lysophosphatidylinositol acyltransferase 1-interacting protein.
Hirata Y; Yamamori N; Kono N; Lee HC; Inoue T; Arai H
Genes Cells; 2013 May; 18(5):397-409. PubMed ID: 23510452
[TBL] [Abstract][Full Text] [Related]
11. Hepatic deletion of Mboat7 (LPIAT1) causes activation of SREBP-1c and fatty liver.
Xia M; Chandrasekaran P; Rong S; Fu X; Mitsche MA
J Lipid Res; 2021; 62():100031. PubMed ID: 32859645
[TBL] [Abstract][Full Text] [Related]
12. MBOAT7 in liver and extrahepatic diseases.
Caddeo A; Spagnuolo R; Maurotti S
Liver Int; 2023 Nov; 43(11):2351-2364. PubMed ID: 37605540
[TBL] [Abstract][Full Text] [Related]
13. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
[TBL] [Abstract][Full Text] [Related]
14. Obesity-linked suppression of membrane-bound
Helsley RN; Varadharajan V; Brown AL; Gromovsky AD; Schugar RC; Ramachandiran I; Fung K; Kabbany MN; Banerjee R; Neumann CK; Finney C; Pathak P; Orabi D; Osborn LJ; Massey W; Zhang R; Kadam A; Sansbury BE; Pan C; Sacks J; Lee RG; Crooke RM; Graham MJ; Lemieux ME; Gogonea V; Kirwan JP; Allende DS; Civelek M; Fox PL; Rudel LL; Lusis AJ; Spite M; Brown JM
Elife; 2019 Oct; 8():. PubMed ID: 31621579
[TBL] [Abstract][Full Text] [Related]
15. Membrane-bound
Varadharajan V; Ramachandiran I; Massey WJ; Jain R; Banerjee R; Horak AJ; McMullen MR; Huang E; Bellar A; Lorkowski SW; Gulshan K; Helsley RN; James I; Pathak V; Dasarathy J; Welch N; Dasarathy S; Streem D; Reizes O; Allende DS; Smith JD; Simcox J; Nagy LE; Brown JM
Elife; 2024 Apr; 12():. PubMed ID: 38648183
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte Deletion of Triglyceride-Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in Mice.
Gluchowski NL; Gabriel KR; Chitraju C; Bronson RT; Mejhert N; Boland S; Wang K; Lai ZW; Farese RV; Walther TC
Hepatology; 2019 Dec; 70(6):1972-1985. PubMed ID: 31081165
[TBL] [Abstract][Full Text] [Related]
17. MBOAT7-driven lysophosphatidylinositol acylation in adipocytes contributes to systemic glucose homeostasis.
Massey WJ; Varadharajan V; Banerjee R; Brown AL; Horak AJ; Hohe RC; Jung BM; Qiu Y; Chan ER; Pan C; Zhang R; Allende DS; Willard B; Cheng F; Lusis AJ; Brown JM
J Lipid Res; 2023 Apr; 64(4):100349. PubMed ID: 36806709
[TBL] [Abstract][Full Text] [Related]
18. Genetic determinants of hepatic steatosis and serum cytokeratin-18 fragment levels in Taiwanese children.
Lin YC; Chang PF; Chang MH; Ni YH
Liver Int; 2018 Jul; 38(7):1300-1307. PubMed ID: 29314568
[TBL] [Abstract][Full Text] [Related]
19. The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in humans.
Luukkonen PK; Zhou Y; Hyötyläinen T; Leivonen M; Arola J; Orho-Melander M; Orešič M; Yki-Järvinen H
J Hepatol; 2016 Dec; 65(6):1263-1265. PubMed ID: 27520876
[No Abstract] [Full Text] [Related]
20. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
